TY - JOUR
T1 - Incomplete penetrance for isolated congenital asplenia in humans with mutations in translated and untranslated RPSA exons
AU - Bolze, Alexandre
AU - Boisson, Bertrand
AU - Bosch, Barbara
AU - Antipenko, Alexander
AU - Bouaziz, Matthieu
AU - Sackstein, Paul
AU - Chaker-Margot, Malik
AU - Barlogis, Vincent
AU - Briggs, Tracy
AU - Colino, Elena
AU - Elmore, Aurora C.
AU - Fischer, Alain
AU - Genel, Ferah
AU - Hewlett, Angela
AU - Jedidi, Maher
AU - Kelecic, Jadranka
AU - Krüger, Renate
AU - Ku, Cheng Lung
AU - Kumararatne, Dinakantha
AU - Lefevre-Utile, Alain
AU - Loughlin, Sam
AU - Mahlaoui, Nizar
AU - Markus, Susanne
AU - Garcia, Juan Miguel
AU - Nizon, Mathilde
AU - Oleastro, Matias
AU - Pac, Malgorzata
AU - Picard, Capucine
AU - Pollard, Andrew J.
AU - Rodriguez-Gallego, Carlos
AU - Thomas, Caroline
AU - Bernuth, Horst Von
AU - Worth, Austen
AU - Meyts, Isabelle
AU - Risolino, Maurizio
AU - Selleri, Licia
AU - Puel, Anne
AU - Klinge, Sebastian
AU - Abel, Laurent
AU - Casanova, Jean Laurent
N1 - Funding Information:
ACKNOWLEDGMENTS. We thank the patients and all of their families. Many of the new families in this study contacted us directly and devoted considerable effort and time to their participation in this study. We also thank Yelena Nemirovskaya, Dominick Papandrea, David Hum, Cécile Patissier, Benedetta Bigio, and Maya Chrabieh, who helped with all of the administrative questions and tasks required for this study. This work was supported in part by March of Dimes Grant 1-FY12-440, St. Giles Foundation, National Center for Research Resources and the National Center for Advancing Sciences of the National Institutes of Health Grant 8UL1 TR001866, the French National Agency for Research under the “Investissement d’avenir” program Grant ANR-10-IAHU-01, and the Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence Grant ANR-10-LABX-62-IBEID. A.B. was funded by a fellowship from the Jane Coffin Childs Memorial Fund for Medical Research from July 2014 to November 2015. B. Bosch was supported by a fellowship from the Boehringer Ingelheim Fonds.
Funding Information:
We thank the patients and all of their families. Many of the new families in this study contacted us directly and devoted considerable effort and time to their participation in this study. We also thank Yelena Nemirovskaya, Dominick Papandrea, David Hum, Cécile Patissier, Benedetta Bigio, and Maya Chrabieh, who helped with all of the administrative questions and tasks required for this study. This work was supported in part by March of Dimes Grant 1-FY12-440, St. Giles Foundation, National Center for Research Resources and the National Center for Advancing Sciences of the National Institutes of Health Grant 8UL1 TR001866, the French National Agency for Research under the “Investissement d’avenir” program Grant ANR-10-IAHU-01, and the Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence Grant ANR-10-LABX-62-IBEID. A.B. was funded by a fellowship from the Jane Coffin Childs Memorial Fund for Medical Research from July 2014 to November 2015. B. Bosch was supported by a fellowship from the Boehringer Ingelheim Fonds.
Publisher Copyright:
© 2018 National Academy of Sciences. All Rights Reserved.
PY - 2018/8/21
Y1 - 2018/8/21
N2 - Isolated congenital asplenia (ICA) is the only known human developmental defect exclusively affecting a lymphoid organ. In 2013, we showed that private deleterious mutations in the protein-coding region of RPSA, encoding ribosomal protein SA, caused ICA by haploinsufficiency with complete penetrance. We reported seven heterozygous protein-coding mutations in 8 of the 23 kindreds studied, including 6 of the 8 multiplex kindreds. We have since enrolled 33 new kindreds, 5 of which are multiplex. We describe here 11 new heterozygous ICA-causing RPSA protein-coding mutations, and the first two mutations in the 5′-UTR of this gene, which disrupt mRNA splicing. Overall, 40 of the 73 ICA patients (55%) and 23 of the 56 kindreds (41%) carry mutations located in translated or untranslated exons of RPSA. Eleven of the 43 kindreds affected by sporadic disease (26%) carry RPSA mutations, whereas 12 of the 13 multiplex kindreds (92%) carry RPSA mutations. We also report that 6 of 18 (33%) protein-coding mutations and the two (100%) 5′-UTR mutations display incomplete penetrance. Three mutations were identified in two independent kindreds, due to a hotspot or a founder effect. Finally, RPSA ICA-causing mutations were demonstrated to be de novo in 7 of the 23 probands. Mutations in RPSA exons can affect the translated or untranslated regions and can underlie ICA with complete or incomplete penetrance.
AB - Isolated congenital asplenia (ICA) is the only known human developmental defect exclusively affecting a lymphoid organ. In 2013, we showed that private deleterious mutations in the protein-coding region of RPSA, encoding ribosomal protein SA, caused ICA by haploinsufficiency with complete penetrance. We reported seven heterozygous protein-coding mutations in 8 of the 23 kindreds studied, including 6 of the 8 multiplex kindreds. We have since enrolled 33 new kindreds, 5 of which are multiplex. We describe here 11 new heterozygous ICA-causing RPSA protein-coding mutations, and the first two mutations in the 5′-UTR of this gene, which disrupt mRNA splicing. Overall, 40 of the 73 ICA patients (55%) and 23 of the 56 kindreds (41%) carry mutations located in translated or untranslated exons of RPSA. Eleven of the 43 kindreds affected by sporadic disease (26%) carry RPSA mutations, whereas 12 of the 13 multiplex kindreds (92%) carry RPSA mutations. We also report that 6 of 18 (33%) protein-coding mutations and the two (100%) 5′-UTR mutations display incomplete penetrance. Three mutations were identified in two independent kindreds, due to a hotspot or a founder effect. Finally, RPSA ICA-causing mutations were demonstrated to be de novo in 7 of the 23 probands. Mutations in RPSA exons can affect the translated or untranslated regions and can underlie ICA with complete or incomplete penetrance.
KW - Incomplete penetrance
KW - Isolated congenital asplenia
KW - RPSA
KW - Ribosomopathy
KW - Spleen
UR - http://www.scopus.com/inward/record.url?scp=85051824997&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85051824997&partnerID=8YFLogxK
U2 - 10.1073/pnas.1805437115
DO - 10.1073/pnas.1805437115
M3 - Article
C2 - 30072435
AN - SCOPUS:85051824997
SN - 0027-8424
VL - 115
SP - E8007-E8016
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
IS - 34
ER -